Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether SLx-4090 in combination with statin therapy
will reduce LDL-C in patients with hyperlipidemia more effectively than statin therapy alone.